Clinical Trials
36 trialsSIB
Medical College of Wisconsin
Prospective Clinical Study Comparing PROMS After Adaptive or Conventional Radiotherapy in Prostate Cancer
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response
Centre Oscar Lambret
Evaluation of the Impact of Empty Versus Full Bladder in Patients With Prostate Cancer, RELIEF Trial
Mayo Clinic
METRO
Umeå University
APPROACH
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
OLIGOPELVIS2
Institut Cancerologie de l'Ouest
FAST-ONE
Branch Office of "Hadassah Medical Ltd"
JUMP
Brigham and Women's Hospital
VIRTUAL
Royal Marsden NHS Foundation Trust
BRACE
European Organisation for Research and Treatment of Cancer - EORTC
IOSCAR
Istituto Clinico Humanitas
IP4-CHRONOS
Imperial College London
PRIS
Karolinska Institutet
Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer
Sharp HealthCare
HyBla_RCT
University of Erlangen-Nürnberg Medical School
Adjuvant Hypofractionated Radiotherapy for Prostate Cancer
Changhai Hospital
HypoF-SBRT
University Hospital Freiburg
Tumor TARGET Prostate Cancer
University Health Network, Toronto
ENFORCE
Radboud University Medical Center
MEDCARE
Universitaire Ziekenhuizen KU Leuven
Phase II Study to Evaluate Conventional Radiation Therapy Followed by Radiosurgical Boost in Clinically Localized Prostate Cancer
Georgetown University
ProtoChoice-P
Technische Universität Dresden
Low Dose Hemi-body Radiation For Recurrent Prostate Cancer
Juravinski Cancer Center
Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer
National Taiwan University Hospital
SPCG-15
Karolinska University Hospital
Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T
Roswell Park Cancer Institute
Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer
Fox Chase Cancer Center
3D-Conformal Radiation vs Helical Tomotherapy in Prostate Cancer
Ottawa Hospital Research Institute
Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer
Weill Medical College of Cornell University
Proton Therapy for High Risk Prostate Cancer
Abramson Cancer Center at Penn Medicine
PROGERAD
Institut Cancerologie de l'Ouest
Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer
Dana-Farber Cancer Institute
BOLART
Trans Tasman Radiation Oncology Group
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer
National Cancer Institute (NCI)
MRI/MRSI in Risk Assessment of Prostate Cancer Patients
Memorial Sloan Kettering Cancer Center